COMP <GO>
SYM vs TMO // GROSS PROFIT MARGIN
Symbotic Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: SYM 5
— TMO 9
▲ GROSS PROFIT MARGIN LEADER: TMO
LAST: $37.93 (+1.42%) • MKT CAP: $22.62B
gross-margins
18.80%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
gross-margins
41.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SYM VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SYM | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 18.80% | 41.00% | -22.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -5.00% | 9.30% | -14.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.39% | 2.40% | +0.99 | SYM | /fcf-yield <GO> |
| Operating Margin | -5.10% | 17.40% | -22.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | -0.80% | 15.10% | -15.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 25.70% | 3.90% | +21.80 | SYM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.94 | 4.50 | +2.44 | SYM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.70% | +0.60 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.5 | 59.1 | -17.61 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.94 | +0.17 | SYM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 36.3x | -18.30 | SYM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.62B | $262.22B | -$239.60B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SYM REV | TMO REV | SYM GROSS % | TMO GROSS % | SYM FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.25B | $44.56B | 18.8% | 44.0% | $765.8M | $6.29B |
| FY 2024 | $1.79B | $42.88B | 13.7% | 44.0% | -$100.3M | $7.27B |
| FY 2023 | $1.18B | $42.86B | 44.0% | 44.0% | $177.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SYM // BETA 1.11
TMO // BETA 0.94